American Journal of Ophthalmology
Volume 150, Issue 1 , Pages 10-15.e1 , July 2010

Risk Factors for Recurrent Fibrovascular Proliferation in Aggressive Posterior Retinopathy of Prematurity After Early Vitreous Surgery

,Accepted 10 February 2010.

References 

  1. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123:991–999
  2. Early Treatment for Retinopathy of Prematurity Cooperative G. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684–1694
  3. Chong LP, Machemer R, de Juan E. Vitrectomy for advanced stages of retinopathy of prematurity. Am J Ophthalmol. 1986;102:710–716
  4. Trese MT, Droste PJ. Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity. Ophthalmology. 1998;105:992–927
  5. Greven C, Tasman W. Scleral buckling in stages 4B and 5 retinopathy of prematurity. Ophthalmology. 1990;97:817–820
  6. Hinz BJ, de Juan E, Repka MX. Scleral buckling surgery for active stage 4A retinopathy of prematurity. Ophthalmology. 1998;105:1827–1830
  7. Noorily SW, Small K, de Juan E, Machemer R. Scleral buckling surgery for stage 4B retinopathy of prematurity. Ophthalmology. 1992;99:263–268
  8. Trese MT. Scleral buckling for retinopathy of prematurity. Ophthalmology. 1994;101:23–26
  9. Azuma N, Ishikawa K, Hama Y, et al. Early vitreous surgery for aggressive posterior retinopathy of prematurity. Am J Ophthalmol. 2006;142:636–643
  10. Moshfeghi AA, Banach MJ, Salam GA, et al. Lens-sparing vitrectomy for progressive tractional retinal detachments associated with stage 4A retinopathy of prematurity. Arch Ophthalmol. 2004;122:1816–1818
  11. Lakhanpal RR, Sun RL, Albini TA, et al. Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity. Ophthalmology. 2005;112:1569–1573
  12. Fortes Filho JB, Eckert GU, Procianoy L, et al. Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil. Eye. 2009;23:25–30
  13. Karkhaneh R, Mousavi SZ, Riazi-Esfahani M, et al. Incidence and risk factors of retinopathy of prematurity in a tertiary eye hospital in Tehran. Br J Ophthalmol. 2008;92:1446–1449
  14. Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore. 2005;34:169–178
  15. O'Keefe M, Burke J, Algawi K, Goggin M. Diode laser photocoagulation to the vascular retina for progressively advancing retinopathy of prematurity. Br J Ophthalmol. 1995;79:1012–1014
  16. Schulenburg WE, Tsanaktsidis G. Variations in the morphology of retinopathy of prematurity in extremely low birthweight infants. Br J Ophthalmol. 2004;88:1500–1503
  17. Hartnett ME. Pediatric retina: medical and surgical approaches. In: Philadelphia: Lippincott Williams & Wilkins; 2005;p. 559;xv
  18. Hikichi T, Nomiyama G, Ikeda H, Yoshida A. Vitreous changes after treatment of retinopathy of prematurity. Jpn J Ophthalmol. 1999;43:543–545
  19. Flynn JT, Cassady J, Essner D, et al. Fluorescein angiography in retrolental fibroplasia: experience from 1969–1977. Ophthalmology. 1979;86:1700–1723
  20. Yokoi T. Vascular abnormalities in aggressive posterior retinopathy of prematurity detected by fluorescein angiography. Ophthalmology. 2009;116:1377–1382
  21. Funatsu H, Yamashita H, Noma H, et al. Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin. Invest Ophthalmol Vis Sci. 2003;44:1042–1047
  22. Young TL, Anthony DC, Pierce E, et al. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. J AAPOS. 1997;1:105–110
  23. Nishina S, Yokoi T, Yokoi T, et al. Effect of early vitreous surgery for aggressive posterior retinopathy of prematurity detected by fundus fluorescein angiography. Ophthalmology. 2009;116:2442–2447
  24. Vinekar A, Trese MT, Capone A. Evolution of retinal detachment in posterior retinopathy of prematurity: impact on treatment approach. Am J Ophthalmol. 2008;145:548–555
  25. Travassos A, Teixeira S, Ferreira P, et al. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging. 2007;38:233–237
  26. Kusaka S, Shima C, Wada K, et al. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol. 2008;92:1450–1455
  27. Mintz-Hittner HA, Kuffel RR. Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina. 2008;28:831–838
  28. Honda S, Hirabayashi H, Tsukahara Y, Negi A. Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2008;246:1061–1063
  29. Kita T, Hata Y, Arita R, et al. Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target. Proc Natl Acad Sci U S A. 2008;105:17504–17509
  30. Gondorfer A. Pharmacologic vitreolysis. Dev Ophthalmol. 2007;39:149–156

PII: S0002-9394(10)00110-8

doi: 10.1016/j.ajo.2010.02.005

American Journal of Ophthalmology
Volume 150, Issue 1 , Pages 10-15.e1 , July 2010

Article Tools

* Image Usage & Resolution